According to Swedish Orphan Biovitrum's latest financial reports the company's current revenue (TTM ) is A$3.87 Billion. an increase over the revenue in the year 2023 that were of A$3.09 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | A$3.95 B | 27.81% |
2023 | A$3.09 B | 13.93% |
2022 | A$2.71 B | 11.48% |
2021 | A$2.43 B | 11.3% |
2020 | A$2.18 B | 1.11% |
2019 | A$2.16 B | 46.92% |
2018 | A$1.47 B | 48.23% |
2017 | A$0.99 B | 17.59% |
2016 | A$0.84 B | 60.27% |
2015 | A$0.52 B | 16.74% |
2014 | A$0.45 B | 20.51% |
2013 | A$0.37 B | 34.61% |
2012 | A$0.27 B | -2.13% |
2011 | A$0.28 B | 7.76% |
2010 | A$0.26 B | 36.98% |
2009 | A$0.19 B |